Location History:
- Zürich, CH (2006)
- Helsinki, FI (1997 - 2011)
Company Filing History:
6 out of 525 
2 out of 5 
2 out of 20 
Years Active: 1997-2011
Title: Katri Pajusola: Innovator in Angiogenesis Research
Introduction
Katri Pajusola is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of angiogenesis research, holding a total of nine patents. Her work focuses on the development of innovative methods and compositions that enhance vascular growth and healing.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Modified VEGF-A with improved angiogenic properties." This invention is directed to methods and compositions for creating chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules retain VEGFR-2 binding activity while exhibiting enhanced angiogenic activity compared to native VEGF-A. Another notable patent is for "Processed vascular endothelial growth factor-B polypeptides." These VEGF-B polypeptides, derived from the PDGF family of growth factors, promote the mitosis and proliferation of vascular endothelial cells. The patent includes DNA sequences encoding these polypeptides, pharmaceutical compositions containing them, and antibodies that react with them. The VEGF-B polypeptides are valuable for stimulating angiogenesis and have diagnostic applications.
Career Highlights
Katri Pajusola has worked with esteemed organizations such as the Ludwig Institute for Cancer Research and Helsinki University Licensing Ltd. Oy. Her career is marked by a commitment to advancing scientific knowledge and developing practical applications for her research.
Collaborations
Throughout her career, Pajusola has collaborated with notable scientists, including Kari Alitalo and Ulf Eriksson. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Katri Pajusola's innovative work in angiogenesis research has led to significant advancements in the understanding and application of vascular growth factors. Her contributions continue to impact the scientific community and pave the way for future developments in medical research.